| |
Emerging Biotech Sector in Malaysia
RNCOS E-Services Pvt. Ltd.
Malaysia has effectively witnessed an upsurge in the profitability and development of the domestic biotechnology industry. Malaysian biotech market has been growing at the double d
|
2011 |
1.100,00$ |
| |
Asia Pacific Biotechnology Market (2008-2012)
RNCOS E-Services Pvt. Ltd.
The biotechnology market in the Asia-Pacific region seems very lucrative from investment perspective, as it has enjoyed double-digit growth during the past few years. The industry
|
2010 |
1.600,00$ |
| |
Booming Biotech Market in India
RNCOS E-Services Pvt. Ltd.
Thanks to a large pool of scientific talent, world-class information technology industry, and vibrant pharmaceutical sector, the Indian biotech industry has stupendously grown over
|
2010 |
1.400,00$ |
| |
China Biopharmaceutical Industry Report, 2007-2008
Beijing RIC Information Consulting Co. Ltd
Pharmaceutical industry is a sunrise industry, especially the biopharmaceuticals, which just starts its large-scale industrialization process. Many large biotech and pharmaceutical
|
2007 |
2.000,00$ |
| |
Biopharmaceutical Industry in China, 2004
Beijing RIC Information Consulting Co. Ltd
Report Highlights
|
2004 |
1.000,00$ |
| |
An Evaluation of Product Usage for Molecular Testing with 11 European Countries
HBS Consulting
Anzahl der Labore pro Land / Description of laboratory landscape per country / Anzahl der moelcularen tests pro Erregern und Land / the number of performed molecular tests for 42 pathogens per country / Welche Produkte & hersteller werden verwendet / products/manufacturers per test and country / Ma
|
2004 |
6.500,00€ |
| |
Molecular Diagnostics - Revolution or Hype
HBS Consulting
Welches sind die erfolgversprechendsten technologischen Entwicklungen? / Welches sind die erfolgreichsten Anwendungen / Welches sind die erfolgreichsten NA Ziele? / Welche Aussichten haben Tests die auf der Analyse von einzeln (SNPs) und Gen expression profiles basieren_ / eingehende Analyse der Mar
|
2003 |
2.500,00€ |
| |
Molecular Diagnostics in Cancer Testing
TriMark Publications
Molecular diagnostics is a rapidly-advancing area of research and medicine, with new technologies and applications being continually added. The technologies that come under the umb
|
2011 |
3.400,00$ |
| |
Biotech M&A and Licensing Strategies - Co-development Agreements are Poised to Increase in the Future to Counter Drying Pipelines
GBI Research
Major market trends that are expected to shape the licensing and deal making in biotech industry
/ Key drivers that have a significant impact on licensing and deal making in biotech.
/ Licensing and deal making market trends across five segments which include RNA therapeutics, monoclonal antibodie
|
2011 |
3.500,00$ |
| |
Global Bioinformatics Market Outlook
RNCOS E-Services Pvt. Ltd.
Major countries of the world have always tried to build strategies that ensure better development of strong biotechnology sector and in this aim; bio-informatics has been playing a
|
2011 |
1.000,00$ |
| |
Global Biometric Forecast to 2012
RNCOS E-Services Pvt. Ltd.
Biometric market has been growing as one of the fastest emerging markets for the past few years especially due to rising need for personal security concerns, and the advent of new
|
2011 |
1.400,00$ |
| |
Nanotechnology in Drug Delivery - Technological Improvements and Novel Approaches to Fulfill High Potential
GBI Research
Detailed overview of Nanotechnology in Drug Delivery in pharmaceutical industry along with their use, efficiency and limitation.
/ Annualized market data from 2007 and forecast forward till 2016 along with segmentation by geography.
/ Key market drivers and restraints shaping the Nanotechnology i
|
2010 |
3.500,00$ |
| |
Biotechnology Industry 2010 Yearbook - Top Biologics, Biosimilars, Licensing and Financing, Mergers and Acquisitions
GBI Research
Detailed overview of biotech industry in 2009-2010
/ Key market drivers and restraints,challenges and restraints shaping the biotech industry market
/ Pipeline analysis of the biotech industry along with segmentation by indication, phase and geography
/ Competitive landscape analysis with compe
|
2010 |
3.500,00$ |
| |
Chinese Industrial Biotechnology Industry: An Analysis
Koncept Analytics
Introduction
Biotechnology is one of the significant industries in the global sector of science and technology. After showing tremendous results in pharmaceutical industry (red bi
|
2010 |
800,00$ |
| |
US Biotech Market Analysis
RNCOS E-Services Pvt. Ltd.
Due to rising instances of innovations in information technology, world-class healthcare infrastructure, and active participation by private players, the US biotech industry has st
|
2010 |
1.000,00$ |
| |
Biotechnology Pharmaceutical Market in US 2009-2013
Infiniti Research Limited
Biotechnology Pharmaceutical Market in US 2009-2013 report by Technavio Insights forecasts the Biotechnology Pharmaceutical market to grow at a CAGR of 7.7 percent, with Blood Modi
|
2010 |
1.500,00$ |
| |
Global Top 10 Biotechnology Companies Industry, Financial and SWOT Analysis
Datamonitor
Performance of the global biotechnology market on the basis of sales, volume and respective growth patterns over the past five yearsObtain descriptive profiles of the top ten leading players including strategic initiatives undertaken in the l
|
2009 |
1.895,00$ |
| |
Companion Biomarkers in Drug Development
TriMark Publications
The term "companion biomarker" means that a particular diagnostic test is specifically linked to a therapeutic drug either in drug development or in the clinic. Biomarkers of disea
|
2009 |
3.400,00$ |
| |
Cell-Based Assays for Drug Discovery
TriMark Publications
The area of drug discovery tools is one of the newest and most important sectors of pharmaceutical research and development. The term drug discovery tools usually refers to high-co
|
2009 |
3.400,00$ |
| |
RNA Interference Markets
TriMark Publications
Since its discovery, the naturally occurring RNA (ribonucleic acid) interference effect has been acclaimed as the most exciting technical breakthrough in biological research in the
|
2008 |
3.400,00$ |
| |
Biometrics for Defence 2008
Visiongain
Biometrics refers to automated identification methods using unique human identifiers such as fingerprints and iris and facial patterns. Biometrics, regarded as a sophisticated mean
|
2008 |
2.095,00$ |
| |
The World Generics Market 2006-2011
Visiongain
A summary of the relevant legislation affecting the generics industry
/ A market forecast for the world generics market 2006-2011
/ An assessment of the drivers and restraints of the market during this period
/ A discussion of the attitudes to generics in different regions including the US, Euro
|
2006 |
2.763,00$ |
| |
Production and Market of Lipase in China
CCM International Limited
Production information in 2004-2010
/ Producer information in 2009-2011
/ Demand in 2008-2016
|
2011 |
600,00$ |
| |
Production and Market of Pectinase in China
CCM International Limited
Production information in 2004-2010
/ Producer information in 2009-2011
/ Demand in 2008-2016
|
2011 |
600,00$ |
| |
Production and Market of α-Amylase in China
CCM International Limited
Production information in 2004-2010
/ Producer information in 2011
/ Demand in 2009
|
2011 |
600,00$ |
| |
Production and Market of Gluco-amylase in China
CCM International Limited
Production information in 2004-2010
/ Producer information in 2009-2011
/ Profit margin in 2009
/ Demand in 2007-2016
|
2011 |
600,00$ |
| |
Future of White Biotechnology in China
CCM International Limited
White biotechnology (WB) industry, which is often referred to the third wave in biotechnology, is one of the most promising new approaches to pollution prevention, resource conserv
|
2011 |
8.000,00$ |
| |
Production, Market and Benchmarking of Synthetic Vitamin E in China
CCM International Limited
Currently, China is an important vitamin E producer in the world. It is estimated that over 40% of global vitamin E is produced in China. What is the latest development in China’s
|
2011 |
10.000,00$ |
| |
China Blood Products Industry Report, 2010
Beijing RIC Information Consulting Co. Ltd
In 2009, Chinese blood products market valued nearly RMB7 billion and it will continue to expand in the next two or three years. The main reasons include:
The demand from the do
|
2010 |
1.600,00$ |
| |
China Vaccine Industry Report, 2009-2010
Beijing RIC Information Consulting Co. Ltd
Being one of the world's largest vaccine producers, China not only has many vaccine companies, various vaccine categories and large quantity, but also the human and animal vaccine
|
2010 |
2.000,00$ |
| |
The Funding Landscape for Small Biopharma Ventures, 2010-2015: Trends, strategies and priorities
Business Insights
The funding landscape for small and mid-cap biomedical companies has changed enormously over the past two years, driven by recessive public markets and withdrawal of private equity
|
2010 |
3.835,00$ |
| |
Innovations in Combating Infectious Diseases: Opportunities in therapeutics and diagnostics through application of proteomics, genomics, nanotechnology, and novel sources of lead generation
Business Insights
Infectious disease is not merely a problem of the past; despite significant breakthroughs achieved during the last century in the development of antibiotic, antiviral, and antipara
|
2010 |
3.835,00$ |
| |
Opportunities in Non-Surgical Bio-Implants: Marketed injectable biomaterials, applications, and leading players
Business Insights
Injectable bio-implants provide rapid non-surgical treatments and offer effective replacement, restoration, or modulation of function to lost, damaged, or dysregulated physiology.
|
2010 |
3.835,00$ |
| |
China Biological & Biochemical Products Industry Profile
Beijing Zeefer Consulting Ltd.
Through a comparative analysis on the development of biological & biochemical products industry in 31 provincial regions and 20 major cities in visualized form of data map, the rep
|
2010 |
550,00$ |
| |
Biotech for Wellness: Driving successful R&D and licensing in nutraceuticals through new business models and collaboration
Business Insights
Over the past 5 years all of the major food and beverage companies have undergone a fundamental strategy shift to take into account the increasing consumer focus on health and well
|
2010 |
4.795,00$ |
| |
Future of Red Biotechnology in China
CCM International Limited
Red biotechnology (RB) refers to the biotechnology applied in pharmaceutical production and it has become the most important part in biotechnology industry. About 60% of achievemen
|
2010 |
10.000,00$ |
| |
Building Biotech Technology Transfer Opportunities: Sponsor and developer strategies for success
Business Insights
Drug developers have long been under pressure to introduce new products in an environment of escalating R&D costs, blockbuster patent expiration and resulting generic competition.
|
2010 |
3.835,00$ |
| |
Biomarkers in Late Stage Clinical Trials: Applications, opportunities and activities of leading players
Business Insights
Understand and evaluate the growth potential of emerging technologies.
/ Understand biomarker activity in clinical trials of leading market players.
/ Gain knowledge about the relative importance of the biomarker late stage clinical trials technologies in the next five years for investment opport
|
2010 |
3.835,00$ |
| |
Ribonucleic Acid (RNA) Therapeutics - Strong Potential to Address Unmet Needs in Pharma
GBI Research
Detailed market characterization including evaluation of market potential, annual cost of therapy and treatment usage patterns
/ Key technologies that have created significant impact on research and development of RNA therapeutics
/ Key factors that can drive the RNA therapeutics market potenti
|
2010 |
3.500,00$ |
| |
Stem Cell Research - Market Trends, Investment Trends and Pipeline Analysis
GBI Research
Unmet needs and opportunity analysis for therapies that are currently in pipeline.
/ Market characterization including market sizing, technology adoption framework and business models for the stem cell market.
/ A cross-country analysis for regulatory framework, investments, research clusters an
|
2010 |
3.500,00$ |
| |
Biomarkers in Drug Discovery - Optimizing Drug Discovery Timeline and Costs
GBI Research
Market Potential and Pipeline Analysis of biomarkers by phase of development, therapeutic class and geography.
/ Market Size and forecast of global biomarkers market and biomarkers drug discovery market from 2000 to 2008, forecast forward to 2015.
/ Analysis of Key geographies including the US (Un
|
2010 |
3.500,00$ |
| |
Top 10 Biotechnology Companies - SWOT Analysis, Competitive Benchmarking, Financial Analysis and R&D Pipeline
GBI Research
Market size of the global biotechnology industry and coverage of the changing competitive landscape from 2008 to 2012.
/ Review of key industry drivers and restraints which are likely to impact the global biotechnology industry in the future.
/ Analysis of the competitive positioning of the top 10
|
2010 |
3.500,00$ |
| |
Nanotechnology in Healthcare: Market outlook for applications, tools and materials, and 40 company profiles
Business Insights
The advent of healthcare nanotechnology has had a vast impact in the fields of drug delivery and diagnostics. The role of nanotechnology in healthcare is very important in terms of
|
2010 |
3.835,00$ |
| |
The Future of Biosimilars - Market Forecasts to 2015, Opportunity Analysis and Regulatory Pathways
GBI Research
Analysis on the regulations for biosimilars market in the leading geographies of the world – the US, the UK, Germany, France, Italy, Spain, and Japan
/ Market forecasts and potential for the biosimilars market from 2008 to 2015. The key biologics classes included are human growth hormones, granuloc
|
2009 |
3.500,00$ |
| |
Advances in the Use of Biomarkers in Biochip and Microarray Testing: Innovative technologies, growth opportunities and the future market outlook
Business Insights
Microarrays and biochips are small devices capable of detecting and measuring large numbers of biomarkers simultaneously. Although microarrays have been in research use for over a
|
2009 |
3.835,00$ |
| |
Advances in the Stem Cell Industry: The future impact of innovation, and an evaluation of the commercial landscape
Business Insights
An important milestone in the development of stem cell technology occurred in 2007, when researchers induced human cells into a stem cell state using defined genetic factors. These
|
2009 |
3.835,00$ |
| |
The Global Bioinformatics Market: Market size, forecasts and company profiles
Business Insights
The integration of biology and informatics has been very integral part of the life science applications. Changing trends in the drug discovery procedures such as strict regulations
|
2009 |
3.835,00$ |
| |
Future of Green Biotechnology in China
CCM International Limited
This report is the unique and latest one available in the world to provide good understanding about Green Biotechnology (GB) in China and to find out business opportunities in this
|
2009 |
6.500,00$ |
| |
The Future of White Biotechnology in China
CCM International Limited
The future of white Biotechnology is attractive in China, and considerable progress in white biotechnology has been made in recent years. China’s production of many vitamins and po
|
2009 |
12.000,00$ |
| |
US Biotechnology Sector: Industry Profile
Koncept Analytics
This industry profile helps to gain an insight into the evolution of the industry and competitive dynamics prevalent in the market. It discusses the significant developments in the
|
2008 |
600,00$ |
| |
